Health Care & Life Sciences » Pharmaceuticals | Shanxi Zhendong Pharmaceutical Co. Ltd.

Shanxi Zhendong Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,644
1,904
2,244
3,249
3,680
3,371
Cost of Goods Sold (COGS) incl. D&A
867
1,114
1,267
1,869
1,623
1,246
Gross Income
777
790
978
1,380
2,057
2,125
SG&A Expense
668
730
883
1,130
1,694
2,133
EBIT
98
44
77
244
349
12
Unusual Expense
-
-
-
-
8
152
Non Operating Income/Expense
38
1
2
6
38
99
Interest Expense
25
26
39
34
25
30
Pretax Income
87
49
69
233
361
87
Income Tax
25
14
14
40
70
63
Equity in Affiliates
-
-
-
-
1
-
Consolidated Net Income
62
35
55
193
290
151
Net Income
74
42
65
203
302
147
Net Income After Extraordinaries
74
42
65
203
302
147
Net Income Available to Common
74
42
65
203
302
147
EPS (Basic)
0.13
0.07
0.11
0.28
0.29
0.14
Basic Shares Outstanding
576
576
576
731
1,034
1,035
EPS (Diluted)
0.13
0.07
0.11
0.28
0.29
0.14
Diluted Shares Outstanding
576
576
576
731
1,034
1,035
EBITDA
141
123
164
368
471
140
Other Operating Expense
11
15
18
5
14
4
Non-Operating Interest Income
10
6
7
4
7
9
Minority Interest Expense
12
7
9
10
11
3

About Shanxi Zhendong Pharmaceutical Co.

View Profile
Address
Zhendong Technology Park
Changzhi Shanxi 047100
China
Employees -
Website http://www.zdjt.com
Updated 07/08/2019
Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and distribution of Chinese traditional medicines and western medicines. Its main products include Yanshu injection, Norfloxacin, Shuxuening injection, Guanxinning injection, Amoxicillin Sodium for injection, Cefathiamidine for injection, and Riboflavin Sodium Phosphate for injection. The company was founded on November 22, 1993 and is headquartered in Changzhi, China.